bimekizumab,Secukinumab,risankizumab,Izokibep
ucb biopharma,novartis,Abbvie,Boehringer Ingelheim,ACELYRIN
['bimekizumab', 'thanks']
 thanks for the view. was bimekizumab data lackluster vs ph2? modestly better than coseyntx ph3? any concern on candidiasis?
Interesting